Robert Teasell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Robert Teasell has a total of 262 co-authors. Here are the top co-authors by number of shared publications:
- Cecilia Flores-Sandoval
Lawson Research Institute, St. Joseph's Health Care London, London, Ontario, Canada
19 shared publications - Mark Bayley
From the: Toronto Rehabilitation Institute–University Health Network, Toronto, Ontario, Canada
12 shared publications - Emma A. Bateman
Schulich School of Medicine and Dentistry, Western University
11 shared publications - Sarvenaz Mehrabi
Lawson Research Institute at St. Joseph’s Health Care London, Ontario, Canada
11 shared publications Swati Mehta
Department of Kinesiology, Faculty of Human Kinetics, University of Windsor, Windsor, Ontario, Canada
10 shared publications- Amanda McIntyre
Arthur Labatt Family School of Nursing, Western University, London, ON, Canada
9 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- p. 1-11
Landscape of Canadian Stroke Motor and Cognitive Rehabilitation Trials: Trends, Strengths and Future Directions
This study aims to systematically identify and describe all randomized controlled trials (RCTs) evaluating post-stroke motor and cognitive rehabilitation conducted in Canada, within the broader context of global post-stroke rehabilitation research. The present secondary descriptive/bibliometric analysis used data derived from five integrated systematic reviews conducted by the same research group, from inception to 2024. A subset of data was examined in Canadian trials, including number of RCTs, sample size, participant sex, time post-stroke, methodological quality, intervention types and outcome measures. In total, 106 out of 3602 global RCTs were conducted in Canada. Canadian RCT relative contribution to global research has slowed down over time. Sample size was significantly smaller in the chronic post-stroke phase compared to acute and subacute phases in both Canadian ( p = 0.013) and global trials ( p < 0.001). Compared to global trials, Canadian RCTs had comparable sample size ( p = 0.72) and methodological quality ( p = 0.94) but were more likely to be conducted in the chronic phase ( p = 0.001), evaluate exercise-based and rehabilitation-oriented interventions and assess activity and participation outcome measures. Chronic trials were more likely to be led by academic therapists ( p = 0.031), while the acute and subacute trials were more likely to be led by academic physicians ( p = 0.003). Canadian RCTs have made important contributions to stroke rehabilitation research. However, expanding research into earlier recovery phases, integrating technology-driven interventions and incorporating outcome measures across all three International Classification of Functioning, Disability and Health domains will be important to strengthening Canada’s impact and advancing stroke rehabilitation evidence.
- 14 October 2026
- Published by Cambridge University Press (CUP) in Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
- p. 1-11
Open AccessLandscape of Canadian Stroke Motor and Cognitive Rehabilitation Trials: Trends, Strengths and Future Directions
This study aims to systematically identify and describe all randomized controlled trials (RCTs) evaluating post-stroke motor and cognitive rehabilitation conducted in Canada, within the broader context of global post-stroke rehabilitation research. The present secondary descriptive/bibliometric analysis used data derived from five integrated systematic reviews conducted by the same research group, from inception to 2024. A subset of data was examined in Canadian trials, including number of RCTs, sample size, participant sex, time post-stroke, methodological quality, intervention types and outcome measures. In total, 106 out of 3602 global RCTs were conducted in Canada. Canadian RCT relative contribution to global research has slowed down over time. Sample size was significantly smaller in the chronic post-stroke phase compared to acute and subacute phases in both Canadian ( p = 0.013) and global trials ( p < 0.001). Compared to global trials, Canadian RCTs had comparable sample size ( p = 0.72) and methodological quality ( p = 0.94) but were more likely to be conducted in the chronic phase ( p = 0.001), evaluate exercise-based and rehabilitation-oriented interventions and assess activity and participation outcome measures. Chronic trials were more likely to be led by academic therapists ( p = 0.031), while the acute and subacute trials were more likely to be led by academic physicians ( p = 0.003). Canadian RCTs have made important contributions to stroke rehabilitation research. However, expanding research into earlier recovery phases, integrating technology-driven interventions and incorporating outcome measures across all three International Classification of Functioning, Disability and Health domains will be important to strengthening Canada’s impact and advancing stroke rehabilitation evidence.
- Open Access
- 18 September 2026
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 69 (8) , 102166
The big picture of poststroke aphasia, neglect, and cognitive impairment trials: an overview of 3 systematic reviews
- 18 September 2026
- Published by Elsevier in Annals of Physical and Rehabilitation Medicine
- Vol. 69 (8) , 102166
Open AccessThe big picture of poststroke aphasia, neglect, and cognitive impairment trials: an overview of 3 systematic reviews
- 22 August 2026
- Published by SAGE Publications in International Journal of Stroke
The future of high-dose, high-intensity neurorehabilitation: Consensus-based core recommendations from the fourth Stroke Recovery and Rehabilitation Roundtable
Objective: Convergent evidence indicates that high-dose, high-intensity rehabilitation (HDHI) improves outcomes beyond usual care after stroke, yet implementation remains limited. While questions of optimal dose, timing, and delivery format continue to be refined, the biological plausibility and clinical rationale for HDHI are well established. The fourth Stroke Recovery and Rehabilitation Roundtable convened to identify principal barriers to wider HDHI uptake and derive actionable solutions. Methods: Sixteen international experts from nine countries used a structured consensus process, including surveys, barrier ranking, targeted evidence reviews, and a 2-day in-person meeting. Results: Four interrelated barriers were identified: (1) a conceptual knowledge gap persists regarding HDHI’s targets, mechanisms, and effects; (2) scale and delivery constraints prevent the required dose from being delivered by current conventional care models, making home- and community-based hybrid pathways essential; (3) resistance to change despite the evidence because it places strain on clinicians given their time constraints, inflexible remuneration, and low levels of administrative support; and (4) insufficient system-level enablers to provide longitudinal continuity, patient coordination, and readily accessible technology. Recommendations: The primary limitation to HDHI is implementation capacity, not biological plausibility, or lack of evidence. Implementation research should now proceed in parallel with ongoing efficacy refinement. Priorities include building mechanistic and evidentiary literacy, clarifying professional roles, enabling home-based delivery, aligning reimbursement with long-term economic evaluation, and developing the infrastructure and protocols for scalable longitudinal care.
- 22 August 2026
- Published by SAGE Publications in International Journal of Stroke
The future of high-dose, high-intensity neurorehabilitation: Consensus-based core recommendations from the fourth Stroke Recovery and Rehabilitation Roundtable
Objective: Convergent evidence indicates that high-dose, high-intensity rehabilitation (HDHI) improves outcomes beyond usual care after stroke, yet implementation remains limited. While questions of optimal dose, timing, and delivery format continue to be refined, the biological plausibility and clinical rationale for HDHI are well established. The fourth Stroke Recovery and Rehabilitation Roundtable convened to identify principal barriers to wider HDHI uptake and derive actionable solutions. Methods: Sixteen international experts from nine countries used a structured consensus process, including surveys, barrier ranking, targeted evidence reviews, and a 2-day in-person meeting. Results: Four interrelated barriers were identified: (1) a conceptual knowledge gap persists regarding HDHI’s targets, mechanisms, and effects; (2) scale and delivery constraints prevent the required dose from being delivered by current conventional care models, making home- and community-based hybrid pathways essential; (3) resistance to change despite the evidence because it places strain on clinicians given their time constraints, inflexible remuneration, and low levels of administrative support; and (4) insufficient system-level enablers to provide longitudinal continuity, patient coordination, and readily accessible technology. Recommendations: The primary limitation to HDHI is implementation capacity, not biological plausibility, or lack of evidence. Implementation research should now proceed in parallel with ongoing efficacy refinement. Priorities include building mechanistic and evidentiary literacy, clarifying professional roles, enabling home-based delivery, aligning reimbursement with long-term economic evaluation, and developing the infrastructure and protocols for scalable longitudinal care.
- Open Access
A Novel Approach to Characterizing Patterns of Real-World Upper-Extremity Use During Walking and Activities of Daily Living in People with Subacute Stroke
In accelerometer-based measurement, the inclusion of upper extremity (UE) activity during walking can overestimate real-world functional UE use in people post-stroke. This study introduces a comprehensive, accelerometer-based approach to examining real-world UE use, including the contribution of UE activity during walking, and compares UE use during walking versus ADL-based activities. People with subacute stroke wore bilateral wrist and ankle inertial measurement units (IMU) for one week (24 h/day). Agreement between UE-Total, UE-Continuous Walking and UE-ADL measures were assessed using Bland–Altman analyses. Variables were modeled using linear regression to explore step count, mobility aid use and UE motor impairment as predictors of IMU measures of real-world UE use. Agreement between UE-Total and UE-ADL measures showed minimal bias. Differences between UE-Continuous Walking and UE-ADL varied by mobility aid. UE-Continuous Walking was associated with increased UE activity and relatively greater paretic arm use compared with UE-ADL. Across UE-Continuous Walking and UE-ADL, step count was the strongest predictor of real-world UE use. UE activity during continuous walking exhibits different use patterns as compared to ADL-based activity. Accordingly, separating continuous walking-related UE activity from ADL-based UE use may improve clinical interpretation of IMU measures of real-world UE use in individuals with subacute stroke.
Open AccessA Novel Approach to Characterizing Patterns of Real-World Upper-Extremity Use During Walking and Activities of Daily Living in People with Subacute Stroke
In accelerometer-based measurement, the inclusion of upper extremity (UE) activity during walking can overestimate real-world functional UE use in people post-stroke. This study introduces a comprehensive, accelerometer-based approach to examining real-world UE use, including the contribution of UE activity during walking, and compares UE use during walking versus ADL-based activities. People with subacute stroke wore bilateral wrist and ankle inertial measurement units (IMU) for one week (24 h/day). Agreement between UE-Total, UE-Continuous Walking and UE-ADL measures were assessed using Bland–Altman analyses. Variables were modeled using linear regression to explore step count, mobility aid use and UE motor impairment as predictors of IMU measures of real-world UE use. Agreement between UE-Total and UE-ADL measures showed minimal bias. Differences between UE-Continuous Walking and UE-ADL varied by mobility aid. UE-Continuous Walking was associated with increased UE activity and relatively greater paretic arm use compared with UE-ADL. Across UE-Continuous Walking and UE-ADL, step count was the strongest predictor of real-world UE use. UE activity during continuous walking exhibits different use patterns as compared to ADL-based activity. Accordingly, separating continuous walking-related UE activity from ADL-based UE use may improve clinical interpretation of IMU measures of real-world UE use in individuals with subacute stroke.
- 1 August 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (8) , 2520-2530
Update on Rehabilitation After Stroke: Global Changes and the Continued Importance of Therapy Intensity, Dose, and Timing
Stroke rehabilitation research has seen an unprecedented expansion in the volume of randomized controlled trials. This sets the stage for conducting meta-analyses and network meta-analyses, which help compensate for the large number of smaller phase 2 studies. Over half of randomized controlled trials are conducted in the chronic phase when neuroplasticity is reduced, and the timing of the intervention is not directly generalizable to clinical care. Meanwhile, research productivity has plateaued in high-income countries over the past decade. Therapy intensity and dosage are regarded as important to improving recovery, but the optimal intensity and dose are still uncertain. However, timing also matters when it comes to therapy intensity and dosage. Therapy conducted in the chronic phase, when neuroplasticity has declined, requires a much higher dose to have a comparable impact as the same therapy delivered in the acute/subacute phase. More randomized controlled trials are now being conducted in low- and middle-income countries, focusing on different outcome measures and more acute/subacute randomized controlled trials when compared with trials from high-income countries.
- 1 August 2026
- Published by Wolters Kluwer Health in Stroke
- Vol. 57 (8) , 2520-2530
Update on Rehabilitation After Stroke: Global Changes and the Continued Importance of Therapy Intensity, Dose, and Timing
Stroke rehabilitation research has seen an unprecedented expansion in the volume of randomized controlled trials. This sets the stage for conducting meta-analyses and network meta-analyses, which help compensate for the large number of smaller phase 2 studies. Over half of randomized controlled trials are conducted in the chronic phase when neuroplasticity is reduced, and the timing of the intervention is not directly generalizable to clinical care. Meanwhile, research productivity has plateaued in high-income countries over the past decade. Therapy intensity and dosage are regarded as important to improving recovery, but the optimal intensity and dose are still uncertain. However, timing also matters when it comes to therapy intensity and dosage. Therapy conducted in the chronic phase, when neuroplasticity has declined, requires a much higher dose to have a comparable impact as the same therapy delivered in the acute/subacute phase. More randomized controlled trials are now being conducted in low- and middle-income countries, focusing on different outcome measures and more acute/subacute randomized controlled trials when compared with trials from high-income countries.
- 1 July 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
Patterns of Outcome Measure Utilization in Stroke Rehabilitation Lower Extremity Trials Conducted in Low-to-Middle versus High-Income Countries
This review examined patterns of outcome measure (OM) utilization in randomized controlled trials (RCTs) of post-stroke lower extremity (LE) motor rehabilitation in low-to-middle income (LMICs) and high-income countries (HICs). Searches in MEDLINE, Embase, CINAHL and PsycINFO were conducted in accordance with PRISMA guidelines, up to December 2024. RCTs published in English that studied an adult population with stroke and examined an intervention for LE motor rehabilitation were included. A total of 1,548 RCTs were included. Compared to HICs, LMICs used more generalized impairment and activities of daily living OMs that rely on patient observation rather than direct patient participation (National Institutes of Health Stroke Scale, Modified Ashworth Scale Fugl-Meyer Assessment). In contrast, RCTs from HICs utilized a higher proportion of OMs which required active patient participation as well as more specific OMs focused on muscle strength (e.g., Motricity Index, Maximum Voluntary Isometric/Eccentric Contraction) and functional ambulation (e.g., 10-Metre Walk Test, 6-Minute Walk Test, and Biomechanical Gait Measures). This review underscores the differences between use of OMs in HICs and LMICs and the importance of consensus-based recommended OMs in future stroke motor rehabilitation RCTs trials which can be implemented across rehabilitation settings in both HICs and LMICs.
- 1 July 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
Patterns of Outcome Measure Utilization in Stroke Rehabilitation Lower Extremity Trials Conducted in Low-to-Middle versus High-Income Countries
This review examined patterns of outcome measure (OM) utilization in randomized controlled trials (RCTs) of post-stroke lower extremity (LE) motor rehabilitation in low-to-middle income (LMICs) and high-income countries (HICs). Searches in MEDLINE, Embase, CINAHL and PsycINFO were conducted in accordance with PRISMA guidelines, up to December 2024. RCTs published in English that studied an adult population with stroke and examined an intervention for LE motor rehabilitation were included. A total of 1,548 RCTs were included. Compared to HICs, LMICs used more generalized impairment and activities of daily living OMs that rely on patient observation rather than direct patient participation (National Institutes of Health Stroke Scale, Modified Ashworth Scale Fugl-Meyer Assessment). In contrast, RCTs from HICs utilized a higher proportion of OMs which required active patient participation as well as more specific OMs focused on muscle strength (e.g., Motricity Index, Maximum Voluntary Isometric/Eccentric Contraction) and functional ambulation (e.g., 10-Metre Walk Test, 6-Minute Walk Test, and Biomechanical Gait Measures). This review underscores the differences between use of OMs in HICs and LMICs and the importance of consensus-based recommended OMs in future stroke motor rehabilitation RCTs trials which can be implemented across rehabilitation settings in both HICs and LMICs.
- Open Access
- 25 June 2026
- Published by MDPI AG in Preprints.org
A Novel Approach to Characterizing Patterns of Real‐World Upper‐Extremity Use During Walking and Activities of Daily Living in People with Subacute Stroke
In accelerometer-based measurement, inclusion of upper extremity (UE) activity during walking can overestimate real-world functional UE use in people post-stroke. This study introduces a comprehensive, accelerometer-based approach to examine real-world UE use, including contribution of UE activity during walking, and compares UE use during walking versus ADL-based activities. People with subacute stroke wore bilateral wrist and ankle inertial measurement units (IMU) for one week (24 hrs/day). Agreement between UE-Total, UE-Continuous Walking, and UE-ADL measures were assessed using Bland–Altman analyses. Variables were modeled using linear regression to explore step count, mobility aid use and UE motor impairment as predictors of IMU measures of real-world UE use. Agreement between UE-Total and UE-ADL measures showed minimal bias. Differences between UE-Continuous Walking and UE-ADL varied by mobility aid. UE-Continuous Walking was associated with increased UE activity and relatively greater paretic arm use compared with UE-ADL. Across UE-Continuous Walking and UE-ADL, step count was the strongest predictor of real-world UE use. UE activity during continuous walking exhibits different use patterns as compared to ADL-based activity. Accordingly, separating continuous walking-related UE activity from ADL-based UE use may improve clinical interpretation of IMU measures of real-world UE use in individuals with subacute stroke.
- 25 June 2026
- Published by MDPI AG in Preprints.org
Open AccessA Novel Approach to Characterizing Patterns of Real‐World Upper‐Extremity Use During Walking and Activities of Daily Living in People with Subacute Stroke
In accelerometer-based measurement, inclusion of upper extremity (UE) activity during walking can overestimate real-world functional UE use in people post-stroke. This study introduces a comprehensive, accelerometer-based approach to examine real-world UE use, including contribution of UE activity during walking, and compares UE use during walking versus ADL-based activities. People with subacute stroke wore bilateral wrist and ankle inertial measurement units (IMU) for one week (24 hrs/day). Agreement between UE-Total, UE-Continuous Walking, and UE-ADL measures were assessed using Bland–Altman analyses. Variables were modeled using linear regression to explore step count, mobility aid use and UE motor impairment as predictors of IMU measures of real-world UE use. Agreement between UE-Total and UE-ADL measures showed minimal bias. Differences between UE-Continuous Walking and UE-ADL varied by mobility aid. UE-Continuous Walking was associated with increased UE activity and relatively greater paretic arm use compared with UE-ADL. Across UE-Continuous Walking and UE-ADL, step count was the strongest predictor of real-world UE use. UE activity during continuous walking exhibits different use patterns as compared to ADL-based activity. Accordingly, separating continuous walking-related UE activity from ADL-based UE use may improve clinical interpretation of IMU measures of real-world UE use in individuals with subacute stroke.
- 7 June 2026
- Published by Springer Nature in Spinal Cord
- Vol. 64 (7) , 581-587
Female participation in randomized controlled trials of motor rehabilitation after spinal cord injury: a systematic review
Systematic Review OBJECTIVES: The objective of this study was to investigate female participation in spinal cord injury (SCI) motor rehabilitation randomized controlled trials (RCTs) which included the overall proportion of female participants and how this proportion changed with time post-injury (TPI), study quality and the intervention investigated. Systematic searches were conducted in MEDLINE, Embase, PsycInfo and CINAHL databases inclusive to December 31, 2024. Study eligibility included RCTs or RCT crossovers published in English and investigated an intervention for motor rehabilitation on adult participants with traumatic and/or non-traumatic SCI. Data from the RCTs was extracted and summarized using online Excel, with statistical analyses conducted in RStudio. Overall, 252 RCTs met the inclusion criteria and were included in the dataset. Of these, 237 RCTs reported the sex of participants. The overall proportion of female participants was 22.4%, with no significant changes between 2000 and 2024. No significant differences were found between the proportion of female participants and TPI. High quality studies had significantly higher female participation compared to low quality studies (p = 0.008). Significantly higher female participation was found in RCTs investigating technology-based interventions (p < 0.001), with no significant differences found in pharmacological or non-technology-based interventions. The underrepresentation of female participants in studies of SCI motor rehabilitation limits the generalizability of research results and potentially hinders the availability of rehabilitation strategies for female individuals. Understanding what challenges may be preventing higher enrollment and implementing recruitment strategies may aid in increasing the number of female participants in SCI rehabilitation RCTs.
- 7 June 2026
- Published by Springer Nature in Spinal Cord
- Vol. 64 (7) , 581-587
Female participation in randomized controlled trials of motor rehabilitation after spinal cord injury: a systematic review
Systematic Review OBJECTIVES: The objective of this study was to investigate female participation in spinal cord injury (SCI) motor rehabilitation randomized controlled trials (RCTs) which included the overall proportion of female participants and how this proportion changed with time post-injury (TPI), study quality and the intervention investigated. Systematic searches were conducted in MEDLINE, Embase, PsycInfo and CINAHL databases inclusive to December 31, 2024. Study eligibility included RCTs or RCT crossovers published in English and investigated an intervention for motor rehabilitation on adult participants with traumatic and/or non-traumatic SCI. Data from the RCTs was extracted and summarized using online Excel, with statistical analyses conducted in RStudio. Overall, 252 RCTs met the inclusion criteria and were included in the dataset. Of these, 237 RCTs reported the sex of participants. The overall proportion of female participants was 22.4%, with no significant changes between 2000 and 2024. No significant differences were found between the proportion of female participants and TPI. High quality studies had significantly higher female participation compared to low quality studies (p = 0.008). Significantly higher female participation was found in RCTs investigating technology-based interventions (p < 0.001), with no significant differences found in pharmacological or non-technology-based interventions. The underrepresentation of female participants in studies of SCI motor rehabilitation limits the generalizability of research results and potentially hinders the availability of rehabilitation strategies for female individuals. Understanding what challenges may be preventing higher enrollment and implementing recruitment strategies may aid in increasing the number of female participants in SCI rehabilitation RCTs.
- 27 May 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
A Sudden Decline in Global Stroke Rehabilitation Randomized Controlled Trials and Female Enrollment Associated With the COVID-19 Pandemic
Objective: To examine the impact of the COVID-19 pandemic on the publication of randomized controlled trials (RCTs) of motor and cognitive stroke rehabilitation and on female enrollment across trials. Design: Data for this manuscript was obtained from a unique database of RCTs on post-stroke motor and cognitive rehabilitation, developed by conducting five systematic reviews, up to December 2024. Results: A total of 3,602 RCTs on motor and cognitive post-stroke rehabilitation were analyzed, 1,623 on upper extremity, 1,548 on lower extremity, and 596 on cognitive rehabilitation. A decline in RCT publications was observed in 2023 compared with 2022, with the observed number of RCTs being 28.8% lower than predicted by regression model, followed by a rebound in 2024. This decline was accompanied by a significant reduction in female recruitment across all world regions. Overall female enrollment was 39.4%, decreased to 33.4% in 2023 and rebounded to 38.9% in 2024. Conclusions: Our analysis of 3,602 stroke rehabilitation RCTs showed a sudden decline both in publication of trials and female enrollment in 2023, which then partially rebounded in 2024. We speculate that the pandemic led to significant burdens for researchers conducting RCTs, which in turn resulted in publication delays, compared to previous years.
- 27 May 2026
- Published by Wolters Kluwer Health in American Journal of Physical Medicine & Rehabilitation
A Sudden Decline in Global Stroke Rehabilitation Randomized Controlled Trials and Female Enrollment Associated With the COVID-19 Pandemic
Objective: To examine the impact of the COVID-19 pandemic on the publication of randomized controlled trials (RCTs) of motor and cognitive stroke rehabilitation and on female enrollment across trials. Design: Data for this manuscript was obtained from a unique database of RCTs on post-stroke motor and cognitive rehabilitation, developed by conducting five systematic reviews, up to December 2024. Results: A total of 3,602 RCTs on motor and cognitive post-stroke rehabilitation were analyzed, 1,623 on upper extremity, 1,548 on lower extremity, and 596 on cognitive rehabilitation. A decline in RCT publications was observed in 2023 compared with 2022, with the observed number of RCTs being 28.8% lower than predicted by regression model, followed by a rebound in 2024. This decline was accompanied by a significant reduction in female recruitment across all world regions. Overall female enrollment was 39.4%, decreased to 33.4% in 2023 and rebounded to 38.9% in 2024. Conclusions: Our analysis of 3,602 stroke rehabilitation RCTs showed a sudden decline both in publication of trials and female enrollment in 2023, which then partially rebounded in 2024. We speculate that the pandemic led to significant burdens for researchers conducting RCTs, which in turn resulted in publication delays, compared to previous years.